Press release
Deadline on March 13th coming up in Lawsuit for Investors in Bioventus Inc. (NASDAQ: BVS)
A Deadline is coming up on March 13, 2023 in the lawsuit for certain investors in Bioventus Inc. (NASDAQ: BVS).
Investors who purchased shares of Bioventus Inc. (NASDAQ: BVS) have certain options and there are strict and short deadlines running. Deadline: March 13, 2023. NASDAQ: BVS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Middle District of North Carolina the plaintiff alleges on behalf of purchasers of Bioventus Inc. (NASDAQ: BVS) common shares who purchased NASDAQ: BVS shares pursuant and/or traceable to the Offering Documents issued in connection with the February 11, 2021 IPO and/or between February 11, 2021 and November 21, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Defendants failed to disclose that Bioventus suffered from significant liquidity issues, that the Company's rebate practices were unsustainable, that accordingly, Defendants overstated the Company's business and financial prospects, that Bioventus maintained deficient disclosure controls and procedures and internal control over financial reporting with respect to the timely recognition of quarterly rebates, and that all the foregoing increased the risk that the Company would be forced to recognize a significant non-cash impairment charge, could not timely file one or more of its financial reports, would have to amend one or more of its financial statements, and could not meet its financial obligations as they came due.
Those who purchased shares of Bioventus Inc. (NASDAQ: BVS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on March 13th coming up in Lawsuit for Investors in Bioventus Inc. (NASDAQ: BVS) here
News-ID: 2948672 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Bioventus
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix …
The latest study released on the Global Orthobiologics Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Orthobiologics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Osgood-Schlatter Market is Experiencing Significant Growth | Bioventus, Acumed, …
The Latest published market study on Global Osgood-Schlatter Market provides an overview of the current market dynamics in the Osgood-Schlatter, as well as what our survey respondents all outsourcing decision-makers predict the market will look like in 2032. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players that are…
Bioprosthetics Market Is Booming So Rapidly | Sorin Group, Bioventus, LeMaitre
The latest study released on the Global Bioprosthetics Market by USD Analytics Market evaluates market size, trend, and forecast to 2032. The Bioprosthetics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Advanced Wound Care Market Rewriting Long Term Growth Story | Baxter, Hartmann, …
The latest study released on the Global Advanced Wound Care Market by USD Analytics Market evaluates market size, trend, and forecast to 2032. The Advanced Wound Care market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the…
Tendonitis Treatment Market Is Booming So Rapidly | Bayer, AbbVie, Bioventus
USD Analytics Market published a new research publication on "Global Tendonitis Treatment Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study, you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market-associated stakeholders. The growth of the Tendonitis Treatment market was mainly driven by the increasing R&D spending across the world.
Major players profiled in the study are:
Pfizer,…
Investigation announced for Investors in Bioventus Inc. (NASDAQ: BVS) shares
An investigation was announced for investors of Bioventus Inc. (NASDAQ: BVS) shares over potential securities laws violations by Bioventus Inc.
Investors who purchased shares of Bioventus Inc. (NASDAQ: BVS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Bioventus Inc. regarding its business, its prospects and its operations were materially…
